Krka DD (LTS:0HLK) Research & Development: €190 Mil (TTM As of Mar. 2026)


LTS:0HLK Krka DD LTS:0HLK
78 GF Score
Price €64.80
GF Value €38.09
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Krka DD Research & Development?

Krka DD LTS:0HLK 78 Research & Development is €190 Mil as of Mar. 2026. GuruFocus rates LTS:0HLK with a GF Score™ of 78/100 and a GF Value™ of €38.09 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Krka DD's Research & Development for the three months ended in Mar. 2026 was €51 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €190 Mil.

Krka DD  (LTS:0HLK) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Krka DD Research & Development Related Terms

Krka DD Research & Development Historical Data

* Premium members only.

The historical data trend for Krka DD's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krka DD Research & Development Chart

Krka DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 154.56 162.58 178.58 184.86 188.16

Krka DD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.52 45.34 48.88 44.43 51.37
LTS:0HLK
78GF Score
Krka DD LTS:0HLK
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krka DD Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €190 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €190 Mil mean?
Krka DD (LTS:0HLK) has a Research & Development of €190 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Krka DD and its competitors.
Is Krka DD's Research & Development too high?
Krka DD's current Research & Development is €190 Mil. Overall, Krka DD has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krka DD's Research & Development compare to ZTS and UTHR?
Krka DD's Research & Development of €190 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Krka DD and its competitors. Krka DD's current Research & Development is €190 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krka DD stock overvalued right now?
Based on GuruFocus' analysis, Krka DD (LTS:0HLK) is currently considered Significantly Overvalued. The stock's GF Value™ is €38.09, compared to a current price of €64.80 — trading 70.1% above its estimated fair value. The current Research & Development is €190 Mil. Krka DD's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Krka DD (LTS:0HLK), the current Research & Development is €190 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krka DD (LTS:0HLK) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of €64.80 is trading 70.1% above its estimated GF Value™ of €38.09. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for LTS:0HLK:

  • Research & Development: €190 Mil
  • GF Value™: €38.09 vs. price of €64.80 (70.1% above fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the LTS:0HLK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
78GF Score

Get the complete analysis for LTS:0HLK

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.80
Price
€38.09
GF Value